AN2-502998

· AN2 Therapeutics, Inc

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for AN2-502998, covering 2026-01-08 to 2026-01-08. Get the full timeline:

Most recent: Clinical Trial Update: First-in-Human Trial of Oral AN2-502998 [Phase 1]